Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers

Dereje Kebebe,1–4 Yuanyuan Liu,1–3 Yumei Wu,1–3 Maikhone Vilakhamxay,1–3 Zhidong Liu,1–3 Jiawei Li1–3 1Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China; 2Institute...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kebebe D, Liu Y, Wu Y, Vilakhamxay M, Liu Z, Li J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/aed79369ff8d4061b9b4ad35deec4975
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aed79369ff8d4061b9b4ad35deec4975
record_format dspace
spelling oai:doaj.org-article:aed79369ff8d4061b9b4ad35deec49752021-12-02T01:39:22ZTumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers1178-2013https://doaj.org/article/aed79369ff8d4061b9b4ad35deec49752018-03-01T00:00:00Zhttps://www.dovepress.com/tumor-targeting-delivery-of-herb-based-drugs-with-cell-penetratingtumo-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Dereje Kebebe,1–4 Yuanyuan Liu,1–3 Yumei Wu,1–3 Maikhone Vilakhamxay,1–3 Zhidong Liu,1–3 Jiawei Li1–3 1Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China; 2Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China; 3Engineering Research Center of Modern Chinese Medicine Discovery and Preparation Technique, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, China; 4School of Pharmacy, Institute of Health Sciences, Jimma University, Jimma, Ethiopia Abstract: Cancer has become one of the leading causes of mortality globally. The major challenges of conventional cancer therapy are the failure of most chemotherapeutic agents to accumulate selectively in tumor cells and their severe systemic side effects. In the past three decades, a number of drug delivery approaches have been discovered to overwhelm the obstacles. Among these, nanocarriers have gained much attention for their excellent and efficient drug delivery systems to improve specific tissue/organ/cell targeting. In order to enhance targeting efficiency further and reduce limitations of nanocarriers, nanoparticle surfaces are functionalized with different ligands. Several kinds of ligand-modified nanomedicines have been reported. Cell-penetrating peptides (CPPs) are promising ligands, attracting the attention of researchers due to their efficiency to transport bioactive molecules intracellularly. However, their lack of specificity and in vivo degradation led to the development of newer types of CPP. Currently, activable CPP and tumor-targeting peptide (TTP)-modified nanocarriers have shown dramatically superior cellular specific uptake, cytotoxicity, and tumor growth inhibition. In this review, we discuss recent advances in tumor-targeting strategies using CPPs and their limitations in tumor delivery systems. Special emphasis is given to activable CPPs and TTPs. Finally, we address the application of CPPs and/or TTPs in the delivery of plant-derived chemotherapeutic agents. Keywords: cancer, nanocarriers, cell-penetrating peptide, targeting drug delivery, herb-based drug, tumor targeting Kebebe DLiu YWu YVilakhamxay MLiu ZLi JDove Medical Pressarticlecancernanocarrierscell penetrating peptidetargeting drug deliveryherb-based drugtumor targetingMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 1425-1442 (2018)
institution DOAJ
collection DOAJ
language EN
topic cancer
nanocarriers
cell penetrating peptide
targeting drug delivery
herb-based drug
tumor targeting
Medicine (General)
R5-920
spellingShingle cancer
nanocarriers
cell penetrating peptide
targeting drug delivery
herb-based drug
tumor targeting
Medicine (General)
R5-920
Kebebe D
Liu Y
Wu Y
Vilakhamxay M
Liu Z
Li J
Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
description Dereje Kebebe,1–4 Yuanyuan Liu,1–3 Yumei Wu,1–3 Maikhone Vilakhamxay,1–3 Zhidong Liu,1–3 Jiawei Li1–3 1Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China; 2Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China; 3Engineering Research Center of Modern Chinese Medicine Discovery and Preparation Technique, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, China; 4School of Pharmacy, Institute of Health Sciences, Jimma University, Jimma, Ethiopia Abstract: Cancer has become one of the leading causes of mortality globally. The major challenges of conventional cancer therapy are the failure of most chemotherapeutic agents to accumulate selectively in tumor cells and their severe systemic side effects. In the past three decades, a number of drug delivery approaches have been discovered to overwhelm the obstacles. Among these, nanocarriers have gained much attention for their excellent and efficient drug delivery systems to improve specific tissue/organ/cell targeting. In order to enhance targeting efficiency further and reduce limitations of nanocarriers, nanoparticle surfaces are functionalized with different ligands. Several kinds of ligand-modified nanomedicines have been reported. Cell-penetrating peptides (CPPs) are promising ligands, attracting the attention of researchers due to their efficiency to transport bioactive molecules intracellularly. However, their lack of specificity and in vivo degradation led to the development of newer types of CPP. Currently, activable CPP and tumor-targeting peptide (TTP)-modified nanocarriers have shown dramatically superior cellular specific uptake, cytotoxicity, and tumor growth inhibition. In this review, we discuss recent advances in tumor-targeting strategies using CPPs and their limitations in tumor delivery systems. Special emphasis is given to activable CPPs and TTPs. Finally, we address the application of CPPs and/or TTPs in the delivery of plant-derived chemotherapeutic agents. Keywords: cancer, nanocarriers, cell-penetrating peptide, targeting drug delivery, herb-based drug, tumor targeting 
format article
author Kebebe D
Liu Y
Wu Y
Vilakhamxay M
Liu Z
Li J
author_facet Kebebe D
Liu Y
Wu Y
Vilakhamxay M
Liu Z
Li J
author_sort Kebebe D
title Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
title_short Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
title_full Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
title_fullStr Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
title_full_unstemmed Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
title_sort tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/aed79369ff8d4061b9b4ad35deec4975
work_keys_str_mv AT kebebed tumortargetingdeliveryofherbbaseddrugswithcellpenetratingtumortargetingpeptidemodifiednanocarriers
AT liuy tumortargetingdeliveryofherbbaseddrugswithcellpenetratingtumortargetingpeptidemodifiednanocarriers
AT wuy tumortargetingdeliveryofherbbaseddrugswithcellpenetratingtumortargetingpeptidemodifiednanocarriers
AT vilakhamxaym tumortargetingdeliveryofherbbaseddrugswithcellpenetratingtumortargetingpeptidemodifiednanocarriers
AT liuz tumortargetingdeliveryofherbbaseddrugswithcellpenetratingtumortargetingpeptidemodifiednanocarriers
AT lij tumortargetingdeliveryofherbbaseddrugswithcellpenetratingtumortargetingpeptidemodifiednanocarriers
_version_ 1718402978817245184